Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser

Core Insights - STRATA Skin Sciences, Inc. announces the addition of the XTRAC® 308 nm excimer laser to the clinical offerings of Johns Hopkins Dermatology, enhancing treatment options for chronic inflammatory and autoimmune skin diseases [1][2] Group 1: Company Overview - STRATA Skin Sciences is a medical technology company focused on developing and marketing innovative dermatologic treatments, including the XTRAC excimer laser, VTRAC lamp systems, and TheraClearX Acne Therapy System [5] - The company employs a unique Partnership Program that offers a fee per treatment cost structure, including on-site training, service, maintenance, and advertising support for practices [6] Group 2: Technology and Clinical Impact - The integration of XTRAC into Johns Hopkins' clinical programs supports advanced, targeted care for conditions like psoriasis, vitiligo, and atopic dermatitis, while also facilitating ongoing clinical research [2][3] - Excimer laser technology is backed by over 300 published peer-reviewed clinical studies, reinforcing its effectiveness in managing inflammatory skin conditions [4] Group 3: Academic Collaborations - STRATA collaborates with leading academic institutions, including New York University, University of California, and Cleveland Clinic, to promote evidence-based dermatologic care and expand access to FDA-cleared phototherapy [3]